Roda, Julie M <br/><br/>
CpG-containing oligodeoxynucleotides act through TLR9 to enhance the NK cell cytokine response to antibody-coated tumor cells.  [electronic resource] 

 -  Journal of immunology (Baltimore, Md. : 1950)  Aug 2005 
 - 1619-27 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0022-1767 
<br/><br/><label>Standard No.: </label>10.4049/jimmunol.175.3.1619  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--pharmacology<br/>Adoptive Transfer<br/>Animals<br/>Antibodies, Monoclonal--metabolism<br/>Antibodies, Monoclonal, Humanized<br/>Cell Line, Tumor<br/>Cells, Cultured<br/>CpG Islands--immunology<br/>Cytokines--biosynthesis<br/>Cytotoxicity, Immunologic--immunology<br/>DNA-Binding Proteins--biosynthesis<br/>Female<br/>Humans<br/>Immunoglobulin G--administration & dosage<br/>Interferon-gamma--biosynthesis<br/>Killer Cells, Natural--immunology<br/>Mice<br/>Mice, Inbred BALB C<br/>Neoplasm Transplantation<br/>Oligodeoxyribonucleotides--administration & dosage<br/>Receptors, Cell Surface--biosynthesis<br/>Toll-Like Receptor 9<br/>Trastuzumab